Correlation Between Medipharm Labs and Bionoid Pharma

Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medipharm Labs Corp and Bionoid Pharma, you can compare the effects of market volatilities on Medipharm Labs and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and Bionoid Pharma.

Diversification Opportunities for Medipharm Labs and Bionoid Pharma

-0.04

Correlation Coefficient

Medipharm Labs  Bionoid Pharma

Good diversification

The 3 months correlation between Medipharm and Bionoid is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and Bionoid Pharma go up and down completely randomly.

Pair Corralation between Medipharm Labs and Bionoid Pharma

Assuming the 90 days horizon Medipharm Labs Corp is expected to under-perform the Bionoid Pharma. But the otc stock apears to be less risky and, when comparing its historical volatility, Medipharm Labs Corp is 4.98 times less risky than Bionoid Pharma. The otc stock trades about -0.01 of its potential returns per unit of risk. The Bionoid Pharma is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Bionoid Pharma on September 19, 2024 and sell it today you would earn a total of  12.00  from holding Bionoid Pharma or generate 120.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Medipharm Labs Corp  vs.  Bionoid Pharma

Medipharm Labs Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's forward indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Bionoid Pharma

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Medipharm Labs and Bionoid Pharma

The main advantage of trading using opposite Medipharm Labs and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.

The idea behind Medipharm Labs Corp and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.